In the cases of ALS and FTD, this regulation is greatly diminished, reflected by hypermetabolism, abnormal adipose tissue deposits, and alterations in the leptin and hypothalamus signalling pathways [39,40,41,99]. This evidence concerns the gene LEP and amyotrophic lateral sclerosis.